Lumicitabine Uses, Dosage, Side Effects and more
Lumicitabine is under investigation in clinical trial NCT03010059 (A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations).
| Attribute | Details |
|---|---|
| Trade Name | Lumicitabine |
| Generic | Lumicitabine |
| Lumicitabine Other Names | ALS-008176, Lumicitabine |
| Type | |
| Formula | C18H25ClFN3O6 |
| Weight | Average: 433.86 Monoisotopic: 433.1415914 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
